Tuesday, February 18, 2025

A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes

New research shows sotagliflozin is the only drug in its class to demonstrate these results.

from Top Health News -- ScienceDaily https://ift.tt/RxP8ynb
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

More than 1,000 genetic switches reveal why female immunity is different

More than 1,000 genetic switches behave differently in male and female immune cells, helping explain why women are much more vulnerable to a...